177 related articles for article (PubMed ID: 36281116)
1. Construction and validation of a novel prognostic model for thyroid cancer based on N7-methylguanosine modification-related lncRNAs.
Zhou Y; Dai X; Lyu J; Li Y; Bao X; Deng F; Liu K; Cui L; Cheng L
Medicine (Baltimore); 2022 Oct; 101(42):e31075. PubMed ID: 36281116
[TBL] [Abstract][Full Text] [Related]
2. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs.
Gao Y; Ren J; Chen K; Guan G
J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248
[TBL] [Abstract][Full Text] [Related]
4. The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis.
Xu Y; Zou X; Mei J
Appl Bionics Biomech; 2022; 2022():1666792. PubMed ID: 36060561
[TBL] [Abstract][Full Text] [Related]
5. Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database.
Zhang Y; Jin T; Shen H; Yan J; Guan M; Jin X
Med Sci Monit; 2019 Dec; 25():9752-9769. PubMed ID: 31856144
[TBL] [Abstract][Full Text] [Related]
6. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
7. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer.
Li Z; Wang H; Deng X; Zhang J; Wang L; Tang W; You W; Nian W
Comb Chem High Throughput Screen; 2022; 25(13):2217-2227. PubMed ID: 35209814
[TBL] [Abstract][Full Text] [Related]
8. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer.
Huang Z; Lou K; Liu H
Front Genet; 2022; 13():1030275. PubMed ID: 36313442
[TBL] [Abstract][Full Text] [Related]
9. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
[TBL] [Abstract][Full Text] [Related]
10. An innovative model based on N7-methylguanosine-related lncRNAs for forecasting prognosis and tumor immune landscape in bladder cancer.
Ren L; Yang X; Liu J; Wang W; Liu Z; Lin Q; Huang B; Pan J; Mao X
Cancer Cell Int; 2023 May; 23(1):85. PubMed ID: 37158958
[TBL] [Abstract][Full Text] [Related]
11. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
[TBL] [Abstract][Full Text] [Related]
12. Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs.
Dai YY; Gao YP; Chen LX; Liu JS; Zeng C; Zhou JD; Wu HL
Front Genet; 2022; 13():930446. PubMed ID: 36110218
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
14. A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification.
Yang L; Wang YR; Mou ZQ; Xiong PF; Deng K; Wen J; Li J
BMC Gastroenterol; 2023 Apr; 23(1):131. PubMed ID: 37081394
[TBL] [Abstract][Full Text] [Related]
15. A novel m7G-related lncRNA risk model for predicting prognosis and evaluating the tumor immune microenvironment in colon carcinoma.
Yang S; Zhou J; Chen Z; Sun Q; Zhang D; Feng Y; Wang X; Sun Y
Front Oncol; 2022; 12():934928. PubMed ID: 35992788
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
Front Genet; 2022; 13():929035. PubMed ID: 36081998
[No Abstract] [Full Text] [Related]
17. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
Xu Y; Chen J; Yang Z; Xu L
Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
[TBL] [Abstract][Full Text] [Related]
18. In Silico Analysis Identifies Differently Expressed lncRNAs as Novel Biomarkers for the Prognosis of Thyroid Cancer.
Rao Y; Liu H; Yan X; Wang J
Comput Math Methods Med; 2020; 2020():3651051. PubMed ID: 32377223
[TBL] [Abstract][Full Text] [Related]
19. N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis.
Wang H; Chen RB; Zhang SN; Zhang RF
BMC Genomics; 2022 Jan; 23(1):33. PubMed ID: 34996349
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of an m7G-Related lncRNAs Signature for Prognostic Prediction and Immune Function Analysis in Endometrial Cancer.
Sun J; Li L; Chen H; Gan L; Guo X; Sun J
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]